Logo image of SOLV.BR

SOLVAC SA-REG (SOLV.BR) Stock Fundamental Analysis

EBR:SOLV - Euronext Brussels - BE0003545531 - Common Stock - Currency: EUR

88.8  -0.2 (-0.22%)

Fundamental Rating

4

Taking everything into account, SOLV scores 4 out of 10 in our fundamental rating. SOLV was compared to 65 industry peers in the Chemicals industry. SOLV has only an average score on both its financial health and profitability. SOLV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SOLV had positive earnings in the past year.
Of the past 5 years SOLV 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: SOLV reported negative operating cash flow in multiple years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

SOLV's Return On Assets of 3.83% is fine compared to the rest of the industry. SOLV outperforms 66.15% of its industry peers.
The Return On Equity of SOLV (4.16%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.11%, SOLV is in line with its industry, outperforming 56.92% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SOLV is below the industry average of 6.60%.
Industry RankSector Rank
ROA 3.83%
ROE 4.16%
ROIC 3.11%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 94.15%, SOLV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SOLV's Profit Margin has improved in the last couple of years.
SOLV's Operating Margin of 97.72% is amongst the best of the industry. SOLV outperforms 100.00% of its industry peers.
SOLV's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 97.72%
PM (TTM) 94.15%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, SOLV has about the same amount of shares outstanding.
The number of shares outstanding for SOLV remains at a similar level compared to 5 years ago.
SOLV has a better debt/assets ratio than last year.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

SOLV has an Altman-Z score of 6.30. This indicates that SOLV is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.30, SOLV belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
SOLV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, SOLV belongs to the top of the industry, outperforming 89.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 6.3
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.30 indicates that SOLV may have some problems paying its short term obligations.
With a Current ratio value of 0.30, SOLV is not doing good in the industry: 96.92% of the companies in the same industry are doing better.
SOLV has a Quick Ratio of 0.30. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
SOLV has a worse Quick ratio (0.30) than 95.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

SOLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.25%.
SOLV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.70% yearly.
Looking at the last year, SOLV shows a very negative growth in Revenue. The Revenue has decreased by -48.83% in the last year.
The Revenue has been growing by 24.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-49.25%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%-77.45%
Revenue 1Y (TTM)-48.83%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%-76.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.12, which indicates a rather expensive current valuation of SOLV.
Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a somewhat cheap valuation: SOLV is cheaper than 66.15% of the companies listed in the same industry.
SOLV is valuated rather cheaply when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.11, the valuation of SOLV can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 100.00% of the companies listed in the same industry.
SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.12
Fwd PE 6.11
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.72
PEG (5Y)0.68
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

SOLV has a Yearly Dividend Yield of 4.56%, which is a nice return.
SOLV's Dividend Yield is rather good when compared to the industry average which is at 3.09. SOLV pays more dividend than 83.08% of the companies in the same industry.
SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.56%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

SOLVAC SA-REG

EBR:SOLV (6/3/2025, 7:00:00 PM)

88.8

-0.2 (-0.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-07 2025-03-07
Earnings (Next)07-30 2025-07-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.90B
Analysts82.5
Price Target152.75 (72.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.56%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.12
Fwd PE 6.11
P/S 17.07
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)4.9
EY5.52%
EPS(NY)14.52
Fwd EY16.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.2
BVpS117.7
TBVpS117.7
PEG (NY)2.72
PEG (5Y)0.68
Profitability
Industry RankSector Rank
ROA 3.83%
ROE 4.16%
ROCE 4.15%
ROIC 3.11%
ROICexc 3.12%
ROICexgc 3.12%
OM 97.72%
PM (TTM) 94.15%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexcg growth 3Y-27.07%
ROICexcg growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z 6.3
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.25%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%-77.45%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.83%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%-76.43%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.11%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A